InvestorsHub Logo
icon url

big-yank

03/12/13 5:14 PM

#779 RE: Robbay #778

As I suggested to milo the other day, I think Q2 numbers have a good potential for an uptick. My "gut" is nothing more than that, but the flu numbers should be helpful and a lift to margins. The rest of the story all boils down to A-B/Boots contribution, if any, the "savings" in the billion dollar consolidation sweepstakes (if any is ever achieved) and attainment of the results promised for numerous other earlier M&A activities that were supposed to be accretive to earnings but have yet to gain clarity and due recognition in any concrete way... home infusion, Duane-Reade ,clinics, drugstore.com, blah/ blah/ blah.

I think Q3 & Q4 are the breakout quarters, up or down, for Walgreens. The next C/C will be a tarot reading of the results for those two pivotal quarters.

My biggest disappointment in FY13 is Skinner's lack of visible impact on Walgreens business plan. I had great hopes for this appointment. To borrow a line from McDonald's current TV campaign, his impact-to-date has been totally "Fishy, Fishy"...

GLTA,

Yank